Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
4
×
Tags
biotech
life sciences
national blog main
new york blog main
4
×
clinical trials
eli lilly
fda
indiana blog main
medical device
san diego blog main
startups
type 1 diabetes
beta bionics
boston blog main
boston top stories
deals
diabetes
indiana top stories
lifesci venture partners
new york top stories
raleigh-durham blog main
san diego top stories
san francisco blog main
seattle blog main
adaptive biotechnologies
alector
allergan
amgen
aphelion capital
apollomics
arrowmark partners
bernie sanders
bigfoot biomedical
bill & melinda gates foundation trust
biolinq
black diamond therapeutics
boehringer ingelheim
boston
boston university
boulder/denver blog main
What
diabetes
4
×
eli
million
patients
startup
adds
advance
appetite
approval
based
beta
bid
bio
biolinq
bionics
biosensor
black
blood
boehringer
bread
butter
buyout
cancer
cash
closed
developing
device
diamond’s
driven
drug
drugs
expand
fallen
fda
giant
glucose
grabbed
hasn’t
heads
hold
Language
unset
Current search:
diabetes
×
photo
×
" new york blog main "
×
@xconomy.com
4 years ago
FDA Rejects Boehringer Ingelheim, Eli Lilly Drug for Type 1 Diabetes
@xconomy.com
5 years ago
Biolinq Adds $4.75M to Advance Glucose Monitoring Biosensor Patch
@xconomy.com
5 years ago
Bio Roundup: #JPM19 Notes, Loxo Buyout, Black Diamond’s Cash & More
@xconomy.com
5 years ago
Beta Bionics Secures $63M as AI-Driven “Pancreas” Heads to Key Tests